Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 18, 2024 12:19 ET | Source: AcedrA BioPharmaceuticals; TaiMed Biologics

TaiMed Biologics and AcedrA BioPharmaceuticals Partner to Commercialize Trogarzo® (Ibalizumab-uiyk) in the Middle East and North Africa Region

TaiMed and AcedrA officially signed an exclusive license, commercialization, and distribution agreement for Trogarzo in the MENA region.
September 22, 2021 08:08 ET | Source: Theratechnologies

Theratechnologies annonce que l’étude sur l’administration de Trogarzo(MD) par injection IV directe a produit des résultats positifs

– Les résultats de l’étude TMB‑302 ne laissent voir aucune différence pharmacocinétique entre l’injection IV directe et la perfusion IV – – Aucun effet indésirable grave n’a été observé – – Le dépôt...
September 22, 2021 08:08 ET | Source: Theratechnologies

Theratechnologies Announces Positive Results for Trogarzo® IV Push Administration Study

- TMB-302 study results demonstrate that there was no difference in pharmacokinetics between IV Push and IV Infusion - - No serious adverse events observed – - sBLA filing planned for Q4 2021 - ...